Latest Breaking News On - N channel selectivity - Page 1 : vimarsana.com

/PRNewswire/ Aisa Pharma, Inc. a private, clinical-stage biopharmaceutical company, today announced it will present data on its clinical drug candidate,.

United statesAndrew sternlichtAisa pharma incAmerican academy of neurologyPrnewswire aisa pharma incEuropean alliance of associationsPositive phaseSystemic sclerosisAmerican academyScientific platform sessionNoveln type specific calcium channel antagonistHas potent activityWhich may have implicationsCertain neuropathic painEuropean allianceNovel daily oral calcium channel blocker